Status:
ENROLLING_BY_INVITATION
Fatal Overdose Review Teams - Research to Enhance Surveillance Systems
Lead Sponsor:
Indiana University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance-Related Disorders
Opioid-Related Disorders
Eligibility:
All Genders
Phase:
NA
Brief Summary
This project seeks to address the overdose epidemic by working with overdose fatality review (OFR) teams. Current OFR practices rely on a case review model where OFR teams assess one or two overdose c...
Eligibility Criteria
Inclusion
- Inclusion Criteria for FORTRESS staff personnel recruited to complete surveys, focus groups and/or interviews:
- 1\) member of local overdose fatality review (OFR) team; OR 2) local county leader of organizations represented by OFR (OFR facilitator, public jail administrators, chief of police, judge, addiction treatment CEO/CFO, public health director, etc.).
- Inclusion criteria for FORTRESS administrative data:
- all residents of Indiana that have experienced fatal and/or non-fatal overdose as identified by administrative data sources.
- Exclusion Criteria
- N/A
Exclusion
Key Trial Info
Start Date :
September 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06084221
Start Date
September 21 2023
End Date
September 30 2027
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University School of Medicine
Indianapolis, Indiana, United States, 46202